VHL vitasora health limited

virax awaiting hiv vaccine trial results

  1. 520 Posts.
    Source: News Bites
    Published 4:08 PM, 9 Aug 2010

    Source: News Bites

    http://www.businessspectator.com.au/bs.nsf/Article/Virax-awaiting-HIV-vaccine-trial-results-869CS?opendocument&src=rss

    Virax Holdings Ltd is awaiting results from the phase IIa cinical trial in South Africa for its HIV therapeutic vaccine, VIR201.

    All immunological laboratory analyses have been completed and data input into the clinical trial database.

    Results are expected in 1-2 weeks.

    VIR201 treats HIV-infected individuals by lowering viral load. Current HIV treatments typically use a combination of antiretroviral therapies which often have unwanted side effects.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.6¢
Change
0.000(0.00%)
Mkt cap ! $44.68M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $156 6.012K

Buyers (Bids)

No. Vol. Price($)
2 167796 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 146386 2
View Market Depth
Last trade - 15.03pm 12/08/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.